Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,688 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
Shingai M, Nomura N, Sekiya T, Ohno M, Fujikura D, Handabile C, Omori R, Ohara Y, Nishimura T, Endo M, Kimachi K, Mitsumata R, Ikeda T, Kitayama H, Hatanaka H, Sobue T, Muro F, Suzuki S, Thanh Nguyen C, Ishigaki H, Nakayama M, Mori Y, Itoh Y, Koutsakos M, Chua BY, Kedzierska K, Brown LE, Jackson DC, Ogasawara K, Kino Y, Kida H. Shingai M, et al. Among authors: ikeda t. Vaccine. 2021 Jun 29;39(29):3940-3951. doi: 10.1016/j.vaccine.2021.05.065. Epub 2021 Jun 2. Vaccine. 2021. PMID: 34090697 Free article.
Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
Sekiya T, Mifsud EJ, Ohno M, Nomura N, Sasada M, Fujikura D, Daito T, Shingai M, Ohara Y, Nishimura T, Endo M, Mitsumata R, Ikeda T, Hatanaka H, Kitayama H, Motokawa K, Sobue T, Suzuki S, Itoh Y, Brown LE, Ogasawara K, Kino Y, Kida H. Sekiya T, et al. Among authors: ikeda t. Vaccine. 2019 Apr 3;37(15):2158-2166. doi: 10.1016/j.vaccine.2019.02.057. Epub 2019 Mar 8. Vaccine. 2019. PMID: 30857932
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
Shiohara M, Suzuki S, Shichinohe S, Ishigaki H, Nakayama M, Nomura N, Shingai M, Sekiya T, Ohno M, Iida S, Kawai N, Kawahara M, Yamagishi J, Ito K, Mitsumata R, Ikeda T, Motokawa K, Sobue T, Kida H, Ogasawara K, Itoh Y. Shiohara M, et al. Among authors: ikeda t. Vaccine. 2022 Jun 26;40(30):4026-4037. doi: 10.1016/j.vaccine.2022.05.045. Epub 2022 May 28. Vaccine. 2022. PMID: 35641357
Neurological prognosis prediction upon arrival at the hospital after out-of-hospital cardiac arrest: R-EDByUS score.
Shimada T, Kawai R, Shintani A, Shibata A, Otsuka K, Ito A, Yamazaki T, Izumiya Y, Fukuda D, Yonemoto N, Tahara Y, Ikeda T; Japanese Circulation Society Resuscitation Science Study JCS-ReSS Group. Shimada T, et al. Among authors: ikeda t. Resuscitation. 2024 May 30:110257. doi: 10.1016/j.resuscitation.2024.110257. Online ahead of print. Resuscitation. 2024. PMID: 38823473
Survival Impact of Glucocorticoid Administration for Adverse Events During Immune Checkpoint Inhibitor Combination Therapy in Patients with Previously Untreated Advanced Renal Cell Carcinoma.
Yoshino M, Ishihara H, Nemoto Y, Mizoguchi S, Ikeda T, Nakayama T, Fukuda H, Yoshida K, Iizuka J, Shimmura H, Hashimoto Y, Kondo T, Takagi T. Yoshino M, et al. Among authors: ikeda t. Target Oncol. 2024 May 31. doi: 10.1007/s11523-024-01069-6. Online ahead of print. Target Oncol. 2024. PMID: 38819770
6,688 results